<DOC>
	<DOCNO>NCT02326922</DOCNO>
	<brief_summary>Research hypothesis : Release levonorgestrel Metraplant-E levonorgestrel release intrauterine contraceptive device inadequate use medical line treatment dysfunctional uterine bleeding . The investigator aim evaluate therapeutic effect intrauterine system ( Metraplant-E ) treatment dysfunctional uterine bleeding .</brief_summary>
	<brief_title>The Use Levonorgestrel-Releasing Device ( Metraplant-E ) Treatment Dysfunctional Uterine Bleeding</brief_title>
	<detailed_description>Primary outcome : The investigator aim evaluate short term release levonorgestrel Metraplant-E levonorgestrel release intrauterine contraceptive device ( IUCDs ) . This trial determine extent intrauterine release levonorgestrel would reduce MBL woman menorrhagia treatment would increase body iron store degree patient satisfaction acceptability treatment patient dysfunctional uterine bleeding . This conducted questionnaire offer woman participate study design Likert scale . Secondary outcome : 1 ) Endometrial biopsy prior 6 month insertion intrauterine system ( Metraplant-E ) . 3 ) Haemoglobin level measurement gm/dl serum ferritin level occasion endometrial biopsy do . 4 ) The amount monthly menstrual blood loss insertion Metraplant-E levonorgestrel release intrauterine contraceptive device use follow score : bleeding index , total bleeding score Pictorial blood loss assessment chart ( PBAC ) . Inclusion criterion : 1 . Women seek contraception . 2 . Women history menorrhagia . 3 . Pre perimenopausal woman marry previously marry . 4 . Failure medical treatment control menorrhagia hemostatics . 5 . Women tolerate copper IUD ( intrauterine device ) due increase amount menstrual blood loss could lead anemia .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>1 . Women seek contraception . 2 . Women history menorrhagia . 3 . Pre perimenopausal woman marry previously marry . 4 . Failure medical treatment control menorrhagia hemostatics . 5 . Women tolerate copper IUD due increase amount menstrual blood loss could lead anemia . 1 . History ectopic pregnancy . 2 . Pregnancy suspicion pregnancy . 3 . Congenital acquire uterine anomaly include fibroid distort uterine cavity . 4 . Acute pelvic inflammatory disease 5 . Postpartum endometritis infect abortion past 3 month . 6 . Known suspected uterine cervical neoplasia unresolved , abnormal Pap smear . 7 . Genital bleed unknown etiology . 8 . Untreated acute cervicitis vaginitis , include bacterial vaginosis lower genital tract infection , infection control . 9 . Acute liver disease liver tumor ( benign malignant ) . 10 . Conditions associate increased susceptibility infection microorganisms . Such condition include , limited , leukemia , acquire immune deficiency syndrome ( AIDS ) , I.V . drug abuse . 11 . A previously insert IUD remove . 12 . Hypersensitivity component product . 13 . Women take anticoagulant 14 . Women coagulopathies due thrombocytopenia platelet dysfunction . 15 . Known suspected carcinoma breast .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Dysfunctional uterine bleeding</keyword>
	<keyword>Metraplant-E</keyword>
	<keyword>Levonorgestrel-releasing intrauterine device</keyword>
	<keyword>Endometrial decidualization</keyword>
</DOC>